ARTICLE | Company News
Exelixis, Genentech antibody deal
June 4, 2005 1:32 AM UTC
DNA and EXEL partnered to discover and develop antibodies to treat cancer, inflammatory diseases and tissue growth and repair. DNA will generate antibodies against targets provided by EXEL. DNA will p...